Comparative Assay of Glutathione S- Transferase (GSTs) Activity of Excretory-Secretory Materials and Somatic Extract of Fasciola spp Parasites
Fascioliasis is a worldwide parasitic disease in human and domestic animals. The causative agents of fascioliasis are Fasciola hepatica and Fasciola gigantica. In the recent years, fasciola resistance to drugs has been reported in the many of publications. Fasciola spp has detoxification system including GST enzyme which may be responsible for its resistance. Therefore , the aim of the study was to assay of GST enzyme activity in fasciola parasites. Fasciola gigantica and Fasciola hepatica helminths were collected from abattoir as a live and cultured in buffer media for 4 h at 37 °C. Excretory-Secretory products were collected and stored in -80◦C. F. gigantica and Fasciola hepatica were homogenized with homogenizing buffer in a glass homogenizer to prepare of somatic extract. Suspension was then centrifuged and supernatant was stored at -80°C. In order to assay the enzyme activity, excretory-secretory and somatic extracts in the form of cocktails (potassium phosphate buffer, reduced glutathione and 1-chloro-2,4-dinitrobenzene substrates) were prepared and their absorbance recorded for 5 minutes at 340 nm. The total and specific GST activity of F. gigantica somatic and ES products were obtained as 2916.00, 272.01 micromole/minute and 1.33, 1.70 micromole/minute/mg protein, respectively. Fasciola hepatica also showed 2705.00, 276.86 micromole/minute and 1.33, 1.52 micromole/minute/mg protein, respectively. These results are important for analysis of parasite survival / resistance to drugs which use for treatment of fascioliasis.
World Health Organization. Fascioliasis: infection with the “neglected” neglected worms. 2009 Mar 12 [cited 2010 Nov 27]. Available from: URL:http://www.who.int/neglected_diseases/integrated_m edia/integrated_media_fascioliasis/en/index.html
Boray JC. Chemotherapy of infections with fasciolidae. In: Boray JC, editor. Immunology, Pathobiology and Control of Fasciolosis. Rahway, NJ: MSD AGVET; 1997;p. 83-97.
Jefferies JR, Campbell AM, van Rossum AJ, Barrett J, Brophy PM. Proteomic analysis of Fasciola hepatica excretory-secretory products. Proteomics 2001;1(9):1128-32.
Brophy PM, Barrett J. Glutathione transferase in helminths. Parasitology 1990;100 Pt 2:345-9.
El-Ghayash AA, Barrett J, Brophy PM. Expression of glutathione S-transferase (GSTs) in Fasciola gigantica derived from three host (cattle, water buffaloes and dankeys). Helminthologia1 1999; 36(1):5-8.
Simon R. Protein Purification Techniques: A Practical Approach. 2nd ed. USA: Oxford University press; 2001.
Farahnak A, Anvar-Seyyedi M, Jalali M, Esharghian MR. Study on glutathione S-transferase inhibition assay by Triclabendazole on fasciola spp. Acta Med Iran 2006;44(6):371-6 .
Liska DJ. The detoxification enzyme systems. Altern Med Rev 1998;3(3):187-98.
Vibanco-Pérez N, Landa-Piedra A. Glutathione Stransferase in helminth parasites. Rev Latinoam Microbiol 1998;40(1-2):73-85.
Moll L, Gaasenbeek CP, Vellema P, Borgsteede FH. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands. Vet Parasitol 2000;91(1-2):153-8.
Thomas I, Coles GC, Duffus K. Triclabendazole-resistant Fasciola hepatica in southwest Wales. Vet Rec 2000;146(7):200.
Ishii Y, Nakamura-Uchiyama F, Nawa Y. A praziquantelineffective fascioliasis case successfully treated with triclabendazole. Parasitol Int 2002;51(2):205-9.